IDH1 and central nervous system cancer: Two additional studies suggest that DUSP-4 may be a diagnostic and prognostic marker for IDH1 mutant gliomas, GNA12 signaling regulation promotes transcriptional and phenotypic responses to GBM tumor invasion (37, 38).